# Wegovy and Ozempic dosage · PepVault guides

Source: https://pepvault.app/guides/wegovy-and-ozempic-dosage

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ

Reviewed November 2026 12 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Wegovy and Ozempic dosage side by side: both FDA labels' four-week steps, the maintenance doses and the max, why they differ and what the trials saw per dose.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 12
- **Questions:** 6
- **Compounds:** 2

## The short answer

Ozempic and Wegovy are the same drug, semaglutide, as a weekly shot. Both labels start at 0.25 mg for four weeks, then 0.5 mg. Ozempic, for type 2 diabetes, stays at 0.5, 1 or 2 mg, with 2 mg the maximum. Wegovy, for weight, climbs through 1 and 1.7 mg to 2.4 mg from week 17, and 7.2 mg is its top adult dose.

Every number checked at its primary source · Nov 20, 2026 · [12 sources](https://pepvault.app/guides/wegovy-and-ozempic-dosage#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** FDA prescribing information for Ozempic and Wegovy, and the randomised trials behind them in people (SUSTAIN 1 and FORTE for Ozempic; STEP 1, 2 and 6, STEP UP and STEP UP T2D for Wegovy); semaglutide is FDA-approved.

## What are the Ozempic and Wegovy dose steps?

Both labels climb in steps of at least four weeks, a process called titration: starting low and raising the dose stepwise, which the labels use to lower the risk of stomach side effects[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). The first eight weeks are identical. After that the two split, because Ozempic stops climbing once blood sugar is controlled and Wegovy keeps going toward a weight dose. This is the current US labelling (the DailyMed versions of June 10 and June 30, 2026)[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).

| Weeks | Ozempic (type 2 diabetes) | Wegovy injection (weight) |
| --- | --- | --- |
| 1–4 | 0.25 mg, the starting dose[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) | 0.25 mg, the starting dose[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |
| 5–8 | 0.5 mg[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) | 0.5 mg[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |
| 9–12 | 0.5 mg, or 1 mg if more blood sugar control is needed after at least 4 weeks on 0.5 mg[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) | 1 mg[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |
| 13–16 | Stays on the dose that controls blood sugar[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) | 1.7 mg[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |
| 17 onward (maintenance) | 0.5 mg, 1 mg or 2 mg, chosen by blood sugar control; 2 mg only after at least 4 weeks on 1 mg[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) | 2.4 mg (recommended) or 1.7 mg[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |
| Maximum | 2 mg once weekly[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) | 7.2 mg once weekly, for adults who have tolerated 2.4 mg for at least 4 weeks and need more weight loss[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |

Look at week 9: the two labels share the first eight weeks, then Ozempic waits on blood sugar while Wegovy keeps climbing.

A maintenance dose is the dose kept once the climb is over. The 7.2 mg step is the newest: the FDA approved it as a new Wegovy dosing regimen on March 19, 2026[12](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-12). Each label also has one special case. Ozempic, for adults with type 2 diabetes and chronic kidney disease, moves to a 1 mg maintenance dose after at least four weeks on 0.5 mg[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1). Wegovy for children 12 and older stops at 2.4 mg or 1.7 mg, and for MASH, a form of fatty liver disease, the maintenance dose is 2.4 mg, with 1.7 mg if 2.4 mg is not tolerated[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).

These are the labels' schedules, not a dose for any one person. The labels leave each step, and the maintenance dose, to the prescriber, weighing response and tolerability[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). Wegovy also comes as a once-daily tablet with its own 30-day steps up to 25 mg[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2); our Wegovy pill guide covers it.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Dose day and step: PepVault reminds you at the time you set and logs each weekly dose with the step-ups your prescriber set, as you enter them.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What rules do both labels share?

- **Once a week, same day:** either shot goes in once a week on the same day, at any time of day, with or without meals[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).
- **Under the skin of the belly, thigh or upper arm**, with a different spot each week[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).
- **Four weeks at least** on a dose before the next step[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). If a Wegovy step is not tolerated, the label suggests delaying the next one by four weeks[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).
- **Changing the day:** Ozempic's label allows it as long as at least two days (more than 48 hours) separate two doses[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1); Wegovy's lets the time of day and the injection site change without any dose change[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).
- **Never two semaglutide products together:** the Wegovy label does not recommend it with any other semaglutide product or any other GLP-1 drug[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).

The missed-dose rules differ, and the missed-dose tool walks through both: Ozempic is taken within five days of the missed day, else skipped[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1); Wegovy is taken if the next dose is more than two days away, else skipped, and after two or more missed doses in a row the label restarts the climb at a lower dose[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).

Why four weeks? Semaglutide has a half-life of about one week, the time the body takes to clear half a dose, so each weekly dose stacks on the last. The Ozempic label puts the steady level, where the weekly dose and the clearance balance, at four to five weeks of weekly dosing[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1). The chart shows how the level builds.

Try it

How Semaglutide builds up

An estimate from a half-life of about 6.9 days, one dose a week for four weeks. The shape of the level, not a measurement.

[Try your own schedule](https://pepvault.app/tools/peptide-half-life-calculator) [Semaglutide in the library](https://pepvault.app/peptides/semaglutide)

**When to get help** If stomach symptoms turn severe or do not settle, both labels' advice is to contact your prescriber[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).

## Why are the Ozempic and Wegovy doses different?

**Different jobs.** The FDA approved Ozempic in December 2017[10](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-10) to improve blood sugar in adults with type 2 diabetes, and later to lower the risk of heart attack, stroke and cardiovascular death in those with heart disease, and of kidney decline in those with chronic kidney disease[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1). Wegovy, approved in June 2021[11](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-11), is for reducing excess weight and keeping it off, alongside diet and activity, plus heart-risk reduction in people with heart disease and obesity or overweight, and MASH[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). Ozempic is not approved for weight loss; its label lists weight change as a trial result, not an indication[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1).

**Different targets.** At the top of the Ozempic range, more drug bought little extra blood sugar control: in SUSTAIN FORTE, 2 mg lowered HbA1c (the three-month blood sugar average) by 0.2 points more than 1 mg, and the 0.8 kg weight gap was not statistically significant[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [9](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-9). For weight, the dose kept paying: in STEP 6, 1.7 mg averaged 9.6% of body weight lost and 2.4 mg 13.2%[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) [5](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-5).

**Different pens.** Ozempic comes in multi-dose pens: the 1 mg and 2 mg pens hold four weekly doses, and the starting pen holds four 0.25 mg doses and two 0.5 mg doses, or four 0.5 mg doses. It also comes in single-dose prefilled syringes of 0.25, 0.5 and 1 mg[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1). Wegovy comes mostly as single-dose pens and syringes, one fixed dose each from 0.25 mg to 2.4 mg; the 7.2 mg dose is a single-dose pen called Wegovy HD, and the Wegovy FlexTouch pen holds four 2.4 mg doses[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). The strengths per mL differ between the two products, so a pen is only ever used for the doses printed on it, and a multi-dose pen is never shared, even with a new needle[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) [2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Semaglutide (oral)

- [Semaglutide (oral): the full reference](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4](https://pepvault.app/research/semaglutide-oasis-4-2025)
- [All 6 studies](https://pepvault.app/research#semaglutide-oral)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [Titration](https://pepvault.app/glossary/titration)
- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Indication](https://pepvault.app/glossary/indication)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## What did the trials see at each dose?

The table prints the labels' figures, counted across everyone randomised whether or not they stayed on the drug; the papers, analysed slightly differently, give close numbers (STEP UP: 18.7% and 15.6%; SUSTAIN 1: HbA1c down 1.45 and 1.55 points)[6](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-6) [8](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-8). Weight change is the average from starting weight; HbA1c change is in percentage points. These are trial averages across groups, not what any one person can expect.

| Trial | Who | Dose and length | Result (against placebo or the lower dose) |
| --- | --- | --- | --- |
| SUSTAIN 1[8](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-8) | 388 adults with type 2 diabetes on diet and exercise | Ozempic 0.5 or 1 mg, 30 weeks | HbA1c down 1.4 and 1.6 points against 0.1; weight down 3.8 and 4.7 kg against 1.2 kg[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) |
| SUSTAIN FORTE[9](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-9) | 961 adults with type 2 diabetes on metformin, some with a sulfonylurea | Ozempic 2 mg against 1 mg, 40 weeks | HbA1c down 2.1 against 1.9 points; weight down 6.4 against 5.6 kg, a gap that was not statistically significant[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1) |
| STEP 1[3](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-3) | 1,961 adults with obesity or overweight and a related condition, no diabetes | Wegovy 2.4 mg, 68 weeks | Down 14.9% against 2.4%[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) [3](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-3) |
| STEP 2[4](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-4) | 1,210 adults with overweight or obesity and type 2 diabetes | Wegovy 2.4 mg, 68 weeks | Down 9.6% against 3.4%[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) [4](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-4) |
| STEP 6[5](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-5) | 401 East Asian adults with obesity or overweight and a related condition, a quarter with type 2 diabetes | Wegovy 1.7 or 2.4 mg, 68 weeks | Down 9.6% and 13.2% against 2.1%[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) [5](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-5) |
| STEP UP[6](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-6) | 1,407 adults with obesity, no diabetes | Wegovy 7.2 or 2.4 mg, 72 weeks | Down 18.8% and 15.5% against 3.9%[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |
| STEP UP T2D[7](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-7) | 512 adults with obesity and type 2 diabetes | Wegovy 7.2 or 2.4 mg, 72 weeks | Down 13.2% and 10.4% against 3.8%[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2) |

Each dose step moves weight further, and at the same dose people with diabetes lose less.

Two patterns run through the table. More drug moved weight further at every step the trials tested, from 1.7 to 2.4 mg and from 2.4 to 7.2 mg[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). And people with type 2 diabetes lost less at the same dose: 9.6% in STEP 2 against 14.9% in STEP 1 at 2.4 mg, two separate trials[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). The Ozempic trials measured blood sugar first, and their weight results are a few kilograms over 30 to 40 weeks[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1).

What each week feels like on the Wegovy climb, from the first dose to the plateau, is in our guide Semaglutide week by week.

**Commonly reported:** the first weeks at 0.25 mg feeling like little is happening, appetite dropping more clearly from 0.5 or 1 mg, and nausea gathering in the days after each step-up before it eases.

## Do the side effects change with the dose?

Mostly, yes, within each trial. On Ozempic, nausea was reported by 15.8% on 0.5 mg and 20.3% on 1 mg against 6.1% on placebo, most nausea, vomiting and diarrhoea came during the climb, and stomach side effects ran 34% on 2 mg against 30.8% on 1 mg[1](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-1). On Wegovy in the STEP UP trials, nausea was 39% on 7.2 mg, 35% on 2.4 mg and 13% on placebo; the clearer rise at 7.2 mg was dysesthesia, an altered skin feeling such as tingling or burning, in 22% against 6% on 2.4 mg[2](https://pepvault.app/guides/wegovy-and-ozempic-dosage#source-2). The semaglutide side-effects page and our Ozempic and Wegovy side-effects guide cover what helps with each one.

## How do you keep track of the steps?

A schedule that changes every four weeks, on a drug taken once a week, is easy to lose count of. The GLP-1 titration calculator lays out the label's calendar from a start date. These are the records that keep it straight:

- **How each step sits:** a note on nausea or appetite after each step-up gives you and your prescriber facts for deciding the next one.

<!--promo-->

**Dose day and step:** PepVault reminds you at the time you set and logs each weekly dose with the step-ups your prescriber set, as you enter them. [Set reminders in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-wegovy-and-ozempic-dosage-inline&mt=8)

<!--/promo-->

<!--promo-->

**Weight:** PepVault's weigh-in log draws your trend in pounds or kilograms, so each step's effect reads against the weeks around it. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-wegovy-and-ozempic-dosage-inline&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. OZEMPIC (semaglutide) injection prescribing information, DailyMed (SPL version 20), June 10, 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
2. WEGOVY (semaglutide) injection and tablets prescribing information, DailyMed (SPL version 19), June 30, 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
3. Wilding JPH et al.; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021. [PubMed 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
4. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021. [PubMed 33667417](https://pubmed.ncbi.nlm.nih.gov/33667417/)
5. Kadowaki T et al. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6). Lancet Diabetes Endocrinol. 2022. [PubMed 35131037](https://pubmed.ncbi.nlm.nih.gov/35131037/)
6. Wharton S et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol. 2025. [PubMed 40961952](https://pubmed.ncbi.nlm.nih.gov/40961952/)
7. Lingvay I et al. Once-weekly semaglutide 7.2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol. 2025. [PubMed 40961953](https://pubmed.ncbi.nlm.nih.gov/40961953/)
8. Sorli C et al. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1). Lancet Diabetes Endocrinol. 2017. [PubMed 28110911](https://pubmed.ncbi.nlm.nih.gov/28110911/)
9. Frías JP et al. Efficacy and safety of once-weekly semaglutide 2.0 mg versus 1.0 mg in patients with type 2 diabetes (SUSTAIN FORTE). Lancet Diabetes Endocrinol. 2021. [PubMed 34293304](https://pubmed.ncbi.nlm.nih.gov/34293304/)
10. US FDA, Drugs@FDA: OZEMPIC, NDA 209637 (original approval December 5, 2017) [accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209637)
11. US FDA, Drugs@FDA: WEGOVY, NDA 215256 (original approval June 4, 2021) [accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215256)
12. US FDA, supplement approval letter, NDA 215256/S-029 (Wegovy injection 7.2 mg weekly dose), March 19, 2026 [accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/215256Orig1s029;218316Orig1s005ltr.pdf)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)

The Zepbound KwikPen step by step from the FDA instructions: new needle, priming, dialing, the hold, storage, how it differs from the vials and a missed dose.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Semaglutide (oral) Studied range: 1.5–25 mg](https://pepvault.app/peptides/semaglutide-oral)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · Getting started

  ### [How to reconstitute semaglutide](https://pepvault.app/guides/how-to-reconstitute-semaglutide)

  How much bacteriostatic water to add to a semaglutide vial, how to mix it, how to draw small doses in insulin-syringe units, and how to store it cold.

  Read the guide
- Guide · Getting started

  ### [Where to inject peptides under the skin](https://pepvault.app/guides/where-to-inject-peptides)

  Where to inject subcutaneous peptides: belly, thigh or upper arm, how far from the navel, why rotating sites matters, and what is normal at the site after.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Semaglutide (oral)

- [Semaglutide (oral): the full reference](https://pepvault.app/peptides/semaglutide-oral)
- [Semaglutide (oral) dose guide](https://pepvault.app/lab/dosage/semaglutide-oral)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Semaglutide (oral): smaller HbA1c drop than orforglipron in ACHIEVE-3](https://pepvault.app/research/semaglutide-achieve-3-2026)
- [Semaglutide (oral) did not slow early Alzheimer's in evoke trials](https://pepvault.app/research/semaglutide-oral-evoke-and-evoke-2026)
- [Semaglutide 25 mg pill: 13.6% weight loss at 64 weeks in OASIS 4](https://pepvault.app/research/semaglutide-oasis-4-2025)
- [All 6 studies](https://pepvault.app/research#semaglutide-oral)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Half-life](https://pepvault.app/glossary/half-life)
- [Titration](https://pepvault.app/glossary/titration)
- [Maintenance dose](https://pepvault.app/glossary/maintenance-dose)
- [Stack](https://pepvault.app/glossary/stack)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Indication](https://pepvault.app/glossary/indication)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
